Rapport Therapeutics, Inc. (RAPP) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading RAPP…

Rapport Therapeutics, Inc. (RAPP) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Rapport Therapeutics, Inc.

RAPP · CIK 2012593

4 · Oct 21, 2026 · Chief Financial Officer Ignelzi Troy A. bought 5,500 shares at $26.10/share ($143.6K)

4

Chief Financial Officer Ignelzi Troy A. bought 5,500 shares at $26.10/share ($143.6K)

Filed: Oct 21, 2026
Period: Oct 21, 2026
Accession: 0001193125-26-428018
Filer: Rapport Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov